ChromaCode Showcases HDPCR Oncology Data on QuantStudio Absolute Q dPCR System at the AMP 2022 Annual Meeting

CARLSBAD, Calif., Nov. 1, 2022 /PRNewswire/ — ChromaCode, Inc., which brings accessible and affordable insights to labs, patients and physicians through its innovative High Definition PCR (HDPCR™) multiplexing solution, announced today that it will present its HDPCR oncology data,…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks